Case Studies NLP-Driven Cancer Mutation Classification
ml Biomedical Research (Applied Project) · Applied Project

NLP-Driven Cancer Mutation Classification

Built an ML workflow for the MSKCC cancer treatment challenge — classifying genetic mutations as driver or passenger mutations using clinical literature and mutation data, demonstrating text classification in a high-stakes biomedical context.

Problem

Distinguishing driver mutations (causally involved in cancer) from passenger mutations (coincidental) requires expert review of clinical literature — a slow, costly, manual process at scale.

Outcome

End-to-end ML pipeline for mutation classification with structured experimental discipline: 64/16/20 train/val/test split, class-balanced evaluation, and documented model comparison.

Overview

The MSKCC cancer treatment challenge is a benchmark problem in biomedical ML: given a genetic mutation and associated clinical literature, classify the mutation as one of several categories describing its role in cancer causation. The difficulty is that the knowledge is encoded in medical text — not in structured data — and the class boundaries are defined by expert consensus, not clean rules.

The Problem

Pathologists manually review clinical papers to classify whether a genetic mutation is a driver (causally involved in tumor progression) or a passenger (a random mutation with no causal role). At the scale of modern genomic sequencing — thousands of mutations per patient — this manual review is a bottleneck. An ML system that could automate or triage this process would directly accelerate cancer treatment research.

Data & Inputs

Approach

Text preprocessing: tokenization, stopword removal, lemmatization, and TF-IDF vectorization. Tested multiple feature representations.

Models: Logistic Regression (strong baseline for text classification), Random Forest, and Naive Bayes. Evaluated on balanced accuracy to handle class imbalance.

Strict experimental protocol: 64% training, 16% cross-validation, 20% holdout test — with class distribution preserved across splits using stratified sampling.

Results & Impact

Technical Detail

Class structure: The MSKCC dataset has 9 mutation classes with significant imbalance — classes 1, 2, and 7 represent the large majority of observations, while classes 4, 6, and 8 are rare. Imbalance handling used stratified cross-validation to preserve the class distribution across all folds, and class-weighted loss functions during model training to prevent the majority classes from dominating the learning signal.

Feature engineering pipeline:

Model comparison:

Evaluation metric: multi-class log loss (the Kaggle competition metric). Log loss penalizes confident wrong predictions heavily — an appropriate metric for medical classification where false certainty is more dangerous than uncertain correct classification.

Key finding: the gene identity feature carried disproportionate discriminative signal. Some genes are almost exclusively associated with one or two mutation classes based on established oncology literature. This reflects the domain structure: mutation classification is not purely a text problem — it is a gene-mutation co-occurrence problem with known biological priors. A system that ignores gene identity loses information that clinical experts would never ignore.

Stack

Python, Scikit-learn, NLTK, Pandas, NumPy, Matplotlib

Stack

Python Scikit-learn NLTK Pandas Numpy Matplotlib
nlp classification biomedical text-classification

Lets collaborate!

Whether you need a quantitative researcher, an machine learning systems builder, or a technical advisor — I'm available for select consulting engagements.

Get in Touch →